Teva Pharmaceutical Industries Ltd (TEVA) insider trading.
In Q3 2026, insiders at Teva Pharmaceutical Industries Ltd reported 15 non-derivative transactions on 8 Forms 3, 4 and 5: 0 open-market purchases and 11 sales worth $17.0M.
- Transactions
- 15
- Purchases (P)
- 0
- Sales (S)
- 11
- Net shares, P minus S
- -441,824
- Insiders
- 8
- Last filed
- 2026-09-22
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Savage Brian | Officer · Interim Chief Legal Officer | 4 | 0 | 3 |
| Weiss Amir | Officer · Chief Accounting Officer | 3 | 0 | 2 |
| Hughes Eric A | Officer · "See ""Remarks""" | 2 | 0 | 1 |
| Jover Placid | Officer · "See ""Remarks""" | 2 | 0 | 1 |
| Mignone Roberto | Director | 1 | 0 | 1 |
| Satchi-Fainaro Ronit | Director | 1 | 0 | 1 |
| Lippman Evan | Officer · EVP, Business Development | 1 | 0 | 1 |
| Zaks Tal Zvi | Director | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-18 | Mignone Roberto | S (D) | 367,600 | $39.06 | 0 | Form 4 |
| 2026-09-18 | Savage Brian | S (D) | 314 | $38.7 | 8,500 | Form 4 |
| 2026-09-18 | Savage Brian | S (D) | 2,525 | $39.15 | 8,814 | Form 4 |
| 2026-09-18 | Savage Brian | S (D) | 4,503 | $38.69 | 11,339 | Form 4 |
| 2026-09-18 | Savage Brian | M (A) | 4,503 | $34.7 | 15,842 | Form 4 |
| 2026-08-21 | Satchi-Fainaro Ronit | S (D) | 415 | $37.25 | 111,986 | Form 4 |
| 2026-08-21 | Weiss Amir | M (A) | 2,500 | $19.61 | 15,571 | Form 4 |
| 2026-08-21 | Weiss Amir | S (D) | 2,500 | $37.63 | 13,071 | Form 4 |
| 2026-08-21 | Weiss Amir | S (D) | 6,945 | $37.61 | 13,071 | Form 4 |
| 2026-08-17 | Lippman Evan | S (D) | 18,600 | $36.57 | 25,591 | Form 4 |
| 2026-08-05 | Zaks Tal Zvi | S (D) | 17 | $34.87 | 73,247 | Form 4 |
| 2026-08-03 | Hughes Eric A | M (A) | 52,744 | — | 160,455 | Form 4 |
| 2026-08-03 | Hughes Eric A | S (D) | 25,578 | $34.88 | 134,877 | Form 4 |
| 2026-08-03 | Jover Placid | S (D) | 12,827 | $34.88 | 6,774 | Form 4 |
| 2026-08-03 | Jover Placid | M (A) | 12,827 | — | 19,601 | Form 4 |
Transaction codes in this quarter
Get TEVA insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=818686&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · TEVA company page · Teva Pharmaceutical Industries Ltd on SEC.gov
Questions
Are insiders buying or selling Teva Pharmaceutical Industries Ltd (TEVA)?
In Q3 2026, insiders at Teva Pharmaceutical Industries Ltd reported 15 non-derivative transactions on 8 Forms 3, 4 and 5: 0 open-market purchases and 11 sales worth $17.0M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Teva Pharmaceutical Industries Ltd insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/teva.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.